Academic Knowledge Library — 12 Pharmacy Subjects & 51 Chapters

12 Canonical Academic Subjects

• 1. Anatomy & Physiology — Organ-system structure, physiological regulation, membrane transport, and autonomic/endocrine integration forming the basis of drug action.
• 2. Pharmacology — General pharmacology, receptor theory, pharmacokinetics (ADME), pharmacodynamics, and systemic organ-class therapeutics.
• 3. Pharmaceutical Chemistry — Inorganic pharmaceutical chemistry, medicinal chemistry structure-activity relationships (SAR), functional groups, and chemical stability.
• 4. Pharmaceutics — Physical pharmacy, dosage form design (solid, liquid, semisolid, sterile parenteral), biopharmaceutics, and novel drug delivery systems.
• 5. Pharmaceutical Analysis — Titrimetric, electrochemical, spectroscopic (UV-Vis, IR, NMR, Mass), and chromatographic (HPLC, GC) quality control methods.
• 6. Pharmacognosy — Crude drugs of natural origin, secondary metabolites (alkaloids, glycosides, terpenoids, flavonoids), standardization, and phytochemistry.
• 7. Microbiology — Bacteriology, virology, mycology, aseptic processing, sterilisation validation, antimicrobial susceptibility, and sterility testing.
• 8. Biochemistry — Bioenergetics, carbohydrate/lipid/amino acid metabolism, enzymology (Michaelis-Menten kinetics), nucleic acids, and clinical biochemistry.
• 9. Pathophysiology — Cellular injury, inflammation, haemodynamic disorders, and molecular pathogenesis of cardiovascular, metabolic, renal, neurological, and infectious diseases.
• 10. Clinical & Hospital Pharmacy — Therapeutic drug monitoring (TDM), ward round pharmacotherapy review, ADR reporting (PvPI), formulary management, and IV admixture safety.
• 11. Community Pharmacy — Prescription screening, patient counselling, Good Pharmacy Practice (GPP), OTC triage, medication adherence, and cold-chain storage.
• 12. Pharmaceutical Jurisprudence & Indian Pharmacy Law — Drugs and Cosmetics Act 1940 & Rules 1945, Pharmacy Act 1948, NDPS Act 1985, DPCO/NPPA pricing, CDSCO schedules (H, H1, X, G), and professional ethics.

All 51 Structured Textbook Chapters

• [PHARM-01] General Pharmacology: Receptor Theory, Dose–Response Relationships & Signal Transduction (2. Pharmacology)
• [PHARM-02] Pharmacokinetics (ADME), Bioavailability, Cytochrome P450 & Elimination Kinetics (2. Pharmacology)
• [PHARM-03] Autonomic Nervous System (ANS) Pharmacology: Cholinergic & Adrenergic Transmission (2. Pharmacology)
• [PHARM-04] Cardiovascular, Renal & Haematological Pharmacology (2. Pharmacology)
• [PHARM-05] Central Nervous System (CNS) Pharmacology: Epilepsy, Psychiatry, Neurodegeneration & Anaesthesia (2. Pharmacology)
• [PHARM-06] Respiratory, Gastrointestinal & Autacoid Pharmacology (2. Pharmacology)
• [PHARM-07] Endocrine & Metabolic Pharmacology: Diabetes, Thyroid, Adrenal Corticosteroids & Bone (2. Pharmacology)
• [PHARM-08] Antimicrobial Chemotherapy, NTEP Tuberculosis, NACO HIV, NVBDCP Malaria & Stewardship (2. Pharmacology)
• [PHARM-09] Autacoids, Analgesics, NSAIDs, Opioids, Gout & Disease-Modifying Antirheumatic Drugs (DMARDs) (2. Pharmacology)
• [PHARM-10] Clinical Toxicology, Emergency Resuscitation Antidotes & Immunopharmacology (10. Clinical & Hospital Pharmacy)
• [PSCI-01] Solid Dosage Forms: Tablets, Granulation Technology, Compression Defects & Coating (4. Pharmaceutics)
• [PSCI-02] Hard & Soft Gelatin Capsules, Liquid Orals, Suspensions & Emulsions (4. Pharmaceutics)
• [PSCI-03] Sterile Dosage Forms: Parenterals (SVP/LVP), Isotonicity, Pyrogens, Lyophilization & Ophthalmics (4. Pharmaceutics)
• [PSCI-04] Biopharmaceutics, BCS Classification, Dissolution Kinetics & Bioequivalence (4. Pharmaceutics)
• [PSCI-05] Physical Pharmaceutics: Rheology, Micromeritics, Interfacial Phenomena & Chemical Kinetics (4. Pharmaceutics)
• [PSCI-06] Novel Drug Delivery Systems (NDDS), Controlled Release Kinetics, Transdermals, Inhalers & Liposomes (4. Pharmaceutics)
• [PSCI-07] Medicinal Chemistry I: Physicochemical Properties, Stereochemistry, Bioisosterism & Prodrug Design (3. Pharmaceutical Chemistry)
• [PSCI-08] Medicinal Chemistry II: Structure–Activity Relationships (SAR) of Major Therapeutic Classes (3. Pharmaceutical Chemistry)
• [PSCI-09] Pharmaceutical Analysis: UV-Vis, FTIR, NMR, Mass Spectrometry, HPLC & Karl Fischer Titration (5. Pharmaceutical Analysis)
• [PSCI-10] Pharmacognosy, Phytochemistry, AYUSH Standardization & Natural Product Drugs (6. Pharmacognosy)
• [HAP-01] Cellular Physiology, Membrane Potentials, Ion Channels & Homeostasis (1. Anatomy & Physiology)
• [HAP-02] Nervous System Anatomy & Physiology: CNS, Blood–Brain Barrier, Synaptic Transmission & Pain Pathways (1. Anatomy & Physiology)
• [HAP-03] Cardiovascular Anatomy, Cardiac Conduction, Action Potentials & Haemodynamics (1. Anatomy & Physiology)
• [HAP-04] Respiratory System Anatomy, Spirometry, Gas Exchange & Acid–Base Regulation (1. Anatomy & Physiology)
• [HAP-05] Renal Anatomy, Nephron Filtration, Tubular Transport, RAAS & Fluid–Electrolyte Balance (1. Anatomy & Physiology)
• [HAP-06] Gastrointestinal & Hepatobiliary Physiology: Parietal Cell Secretion, Enteric Nervous System & Liver Metabolism (1. Anatomy & Physiology)
• [HAP-07] Endocrine System Physiology: Hypothalamic–Pituitary Axis, Pancreatic Islets, Thyroid, Adrenal & Calcium Regulation (1. Anatomy & Physiology)
• [HAP-08] Haematology, Haemostasis, Coagulation Cascade & Anaemia Pathophysiology (9. Pathophysiology)
• [HAP-09] Reproductive System, Maternal–Fetal Physiology, Parturition & Lactation (1. Anatomy & Physiology)
• [HAP-10] Musculoskeletal System, Neuromuscular Junction, Bone Remodelling & Joint Pathophysiology (9. Pathophysiology)
• [HAP-11] Special Senses (Eye & Ear) and Integumentary (Skin) Physiology & Pharmacology (1. Anatomy & Physiology)
• [MICRO-01] Bacterial Ultrastructure, Gram vs Ziehl–Neelsen Staining, Growth Kinetics & Selective Media (7. Microbiology)
• [MICRO-02] Virology, Medical Mycology & Parasitology: Replication Cycles & Therapeutic Targets (7. Microbiology)
• [MICRO-03] Antimicrobial Resistance (AMR) Mechanisms, ESBL, MRSA, NDM-1 & Stewardship (7. Microbiology)
• [MICRO-04] Sterilization Validation, Biological Indicators, D-Value, Z-Value, F0 & Disinfectant Testing (7. Microbiology)
• [MICRO-05] Immunology, Innate vs Adaptive Immunity, Hypersensitivity Reactions (Types I–IV) & Autoimmunity (9. Pathophysiology)
• [MICRO-06] Vaccines, Universal Immunization Programme (UIP India), Cold Chain & Sera/Toxoids (7. Microbiology)
• [MICRO-07] Microbial Assays, Sterility Testing, Bacterial Endotoxin Test (LAL) & Microbial Limit Tests (MLT) (7. Microbiology)
• [MICRO-08] Pharmaceutical Biotechnology: Recombinant DNA, Therapeutic Proteins, Biosimilars & Monoclonal Antibodies (8. Biochemistry)
• [MICRO-09] Hospital Infection Control, Biomedical Waste Management (BMW Rules 2016/2018) & Nosocomial Bundles (10. Clinical & Hospital Pharmacy)
• [REG-01] Drugs and Cosmetics Act 1940 & Rules 1945: Complete Schedules (A–Y), Forms & Licensing (12. Pharmaceutical Jurisprudence & Indian Pharmacy Law)
• [REG-02] Pharmacy Act 1948, PCI Education Regulations (ER 2020), NDPS Act 1985, DPCO 2013 & NLEM 2022 (12. Pharmaceutical Jurisprudence & Indian Pharmacy Law)
• [REG-03] Indian Pharmacopoeia (IP 2022), CDSCO, New Drugs & Clinical Trials (NDCT) Rules 2019 & Ethics Committees (12. Pharmaceutical Jurisprudence & Indian Pharmacy Law)
• [REG-04] Pharmacovigilance Programme of India (PvPI), ADR Causality Assessment, Materiovigilance & Medication Safety (10. Clinical & Hospital Pharmacy)
• [REG-05] Hospital Pharmacy, Pharmacy & Therapeutics Committee (PTC), Formulary Management & Inventory Control (ABC/VED/EOQ) (10. Clinical & Hospital Pharmacy)
• [REG-06] Community & Clinical Pharmacy Practice: Prescription Auditing, Medication Counselling, TDM & Beers Criteria (11. Community Pharmacy)
• [REG-07] National Health Programmes of India (NTEP, NVBDCP, NACO, NHM, PMBJP Jan Aushadhi) & Pharmacist Role (11. Community Pharmacy)
• [REG-08] Schedule M (Revised 2023 WHO-GMP Alignment), Quality Management Systems (QMS), IPQC & Pharmaceutical Validation (12. Pharmaceutical Jurisprudence & Indian Pharmacy Law)
• [REG-09] Biostatistics, Research Methodology, Pharmacoepidemiology & Evidence-Based Medicine (EBM) (10. Clinical & Hospital Pharmacy)
• [REG-10] Pharmacoeconomics (CMA, CEA, CUA, CBA), ICER, QALYs & Health Technology Assessment in India (HTAIn) (10. Clinical & Hospital Pharmacy)
• [REG-11] Pharmaceutical Ethics, Pharmacist Oath, Good Pharmacy Practice (GPP), Digital Health (ABDM) & Intellectual Property (Indian Patents Act 1970 Sec 3(d)) (12. Pharmaceutical Jurisprudence & Indian Pharmacy Law)